Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1

Clinical and Experimental Immunology

Volumn 141, Issue 1, 2005, Pages 141-147

  Yacyshyn, Bruce R ^a,e   Schievella, A ^b   Sewell, K L ^c   Tami, J A ^d  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c GENENTECH INC   (United States)

^d ISIS PHARMACEUTICALS   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alicaforsen; Crohn's disease; Gene polymorphisms; ICAM 1 antisense

Indexed keywords

ALICAFORSEN; AMINOSALICYLIC ACID; ANTI SACCHAROMYCES CEREVISIAE ANTIBODY; ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; CORTICOSTEROID; DNA; FUNGUS ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MESSENGER RNA; NEUTROPHIL CYTOPLASMIC ANTIBODY; PERINUCLEAR ANTINEUTROPHIL CYTOPLASMIC ANTIBODY; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEQUENCE ANALYSIS; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; CROHN DISEASE; GASTROINTESTINAL AGENTS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PHENOTYPE; POLYMORPHISM, GENETIC; SACCHAROMYCES CEREVISIAE; SEVERITY OF ILLNESS INDEX; SOLUBILITY; THIONUCLEOTIDES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21344472110     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02830.x     Document Type: Article

References (39)

1. Ogura Y, Bonene DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411:603-6.
2. Butcher EC. Leucocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67:1033-6.
3. Furie MB, Tancinco MCA, Smith CW. Monoclonal antibodies to leukocyte chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood 1991; 78:2089-97.
4. Oppenheimer-Marks N, Davis LS, Bogue DT et al. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol 1991; 147:2913-21.
5. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 1987; 51:813-9.
6. Diamond MS, Staunton DE, deFougerolles AR et al. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b:/CD18). J Cell Biol 1990; 111:3129-39.
7. Beutler BR. The role of tumor necrosis factor in health and disease. Arthritis Rheum 1999; 26 (Suppl. 57):16-21.
8. Vainer B, Nielson OH, Horn T. Comparative studies of the colonic in situ expression of ICAM-1, -2, and -3, beta 2 integrins (LFA-1, Mac-1, and p150, 95, and PECAM-1 in ulcerative colitis and Crohn's disease. Am J Surg Pathol 2000; 24:1115-24.
9. Pooley N, Ghosh L, Sharon P. Up-regulation of E-selectin and ICAM-1 differs between Crohn's and ulcerative colitis. Dig Dis Sci 1995; 40:219-25.
10. Yacyshyn BR, Lazarovits A, Tsai V, Matejko K. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns. Gastroenterology 1994; 107:1364-71.
11. Souza HS, Elia CC, Spencer J et al. Expression of lymphocyte-endothelial receptor-ligand pairs, α4β7/MAdCAM-1 and OX40/OX 40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut 1999; 45:856-63.
12. Musso A, Condon TP, West GA et al. Regulation of ICAM-1 mediated fibroblast-T cell reciprocal interaction: implications for modulation of gut inflammation. Gastroenterology 1999; 117:546-56.
13. Von Andrian UH, Mackay CR. T cell function and migration: two sides of the same coin. N Eng J Med 2000; 343:1020-34.
14. Liu ZX, Hiwatashi N, Noguchi M et al. Increased expression of costimulatory molecules on peripheral blood monocytes in patients with Crohn's disease. Scand J Gastroenterol 1997; 32:1241-6.
15. Nedospasov SA, Udalova IA, Kuprash DV et al. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus: numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-β) gene. Proc Natl Acad Sci USA 1991; 147:1053-9.
16. Uladova IA, Nedospasov SA, Webb GC et al. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993; 16:180-6.
17. Anonymous. The MHC sequencing consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature 1999; 401:921-3.
18. Yang H, Vora DK, Targan SR et al. ICAM-1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology 1995; 109:440-8.
19. Plevy SE, Targan SR, Yang H et al. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 1996; 110:1053-60.
20. Taylor KD, Plevy SE, Yang H et al. ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease. Gastroenterology 2001; 120:1347-55.
21. O'Callaghan NJ, Adams KE, van Heel DA et al. Association of TNF-alpha-857C with inflammatory bowel disease in the Australian population. Scand J Gastroenterol 2003; 38:533-4.
22. Vasilauskas EA, Kam LY, Karp LC et al. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000; 47:487-96.
23. Quinton JF, Sendid B, Reumaux D et al. Anti-Saccharomyces cereviseae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42:788-91.
24. Lubiniski SM, LaBuda MC, Cho JH et al. Anti-saccharomyces antibodies (ASCA) are highly positive in familial Crohn's disease. Gastroenterology 1999; 116 (Suppl. 4):A766.
25. Mamula P, Telaga GW, Markowitz JE et al. Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol 2002; 97:2005-10.
26. Yacyshyn BR, Chey WY, Goff J et al. Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302) in active steroid dependent Crohn's disease. Gut 2002; 51:30-6.
27. Norris SH, Johnstone JN, Deleon R et al. A competitive ELISA for the anti-intracellular adhesion molecule-1 (anti-ICAM-1) binding activity of monoclonal antibody R6.5 in serum. J Pharma Biomed Anal 1991; 9:211-7.
28. Cush JJ, Rothlein R, Lindsley HB et al. Increased levels of circulating intercellular adhesion molecule 1 in sera of patients with rheumatoid arthritis. Arthritis Rheum 1993; 36:1098-102.
29. Vasiliauskas EA, Plevy SE, Landers CJ et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 1996; 110:1810-9.
30. Macchioni P, Boiardi L, Casali B et al. ICAM-1 gene polymorphisms in Italian patients with rheumatoid arthritis. Clin Exp Rheumatol 2000; 18:553-8.
31. Nejentsev S, Guja C, McCormack R et al. Association of intercellular adhesion molecule-1 gene with type I diabetes. Lancet 2003; 362:1723-24.
32. Boiardi L, Salvarani C, Casali B et al. ICAM-1 gene polymorphisms in Behçet's disease. J Rheumatol 2001; 28:1283-7.
33. McLaren AJ, Marshall SE, Haldar NA et al. Adhesion molecule polymorphisms in chronic renal allograft failure. Kidney Int 1999; 55:1977-82.
34. Amoli MM, Shelley E, Mattey DL et al. ICAM-1 gene polymorphisms in isolated polymyalgia rheumatica. J Rheumatol 2002; 28:502-4.
35. Yang H. Analysis of ICAM-1 gene polymorphism in immunologic subsets of inflammatory bowel disease. Exp Clin Immunogenet 1997; 14:214-25.
36. Braun C, Zahn R, Martin K et al. Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the pANCA status. Clin Immunol 2001; 101:357-60.
37. Hirv K, Seyfarth M, Uibo R et al. Polymorphism in TNF and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and DQ alleles and subclinical markers. Scand J Gastroenterol 1999; 34:1025-32.
38. Matsuzawa J, Sugimura K, Matsuda Y et al. Association between K469E allele of ICAM-1 gene and inflammatory bowel disease in a Japanese population. Gut 2003; 52:75-8.
39. Papa A, Danese S, Armuzzi A et al. Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in different populations [Letter]. Gut 2003; 52:1227-28.